| Sanofi-Aventis (Suisse) SA - Depakine, solution buvable |
| 34734 | | 02 | | Depakine | | solution buvable | | N03AG01 | | Valproic Acid | | 14.06.2013 | | |
|
| Composition |
| natrii valproas 300 mg corresp. acidum valproicum 260.3 mg, saccharinum natricum, natrii hydroxidum, aromatica (arôme orange) cum alcohol benzylicus et ethanolum, aqua purificata ad solutionem pro 1 ml corresp. natrium 43.2 mg. |
| Packungsbestandteile |
| Solution (oral) | | | | | | | | Active Agent | Dose |
|---|
| Sodium Valproate | 300 mg/ml correspond Valproic Acid 260.3 mg/ml |
| | BAG: Active Agent | Dose |
|---|
| Sodium Valproate | 300 mg |
| | | | Inactive agents |
|---|
| Aqua Purificata | | Aromatica (Arôme Orange) cum Alcohol Benzylicus | | Ethanol | | Sodium Hydroxide | | Saccharinum Natricum |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 012 | 60 ml | 12.70 | 30.25 | B | SL | Yes |
|
